Clinical Trials Directory

Trials / Completed

CompletedNCT03050710

Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds

A Prospective, Open-label, Multicenter, Post-market Study Evaluating Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
62 (actual)
Sponsor
Croma-Pharma GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, eligible subjects with moderate to severe nasolabial folds will be treated with Princess® VOLUME Lidocaine and will return for follow-up assessments 2, 4, 24 and 36 weeks after the treatment. A Touch-up treatment may be done at Week 2, if deemed appropriate by the investigator.

Detailed description

This is a prospective, open label, multicenter, post-market investigation. Following informed consent and screening, eligible subjects with moderate to severe nasolabial folds will be treated with Princess® VOLUME Lidocaine, and will return for follow-up assessments 2, 4, 24 and 36 weeks after the treatment. A Touch-up treatment may be done at Week 2, if deemed appropriate by the investigator. The performance of the investigational device will be evaluated by the investigator by assessing severity of nasolabial folds using the Nasolabial Folds Severity Rating Scale (NLF-SRS) (4, 24 and 36 weeks after the treatment and in comparison to Day 0), global aesthetic improvement (4, 24 and 36 weeks after the treatment). The subject will evaluate pain intensity associated with the treatment (at Day 0 and at Week 2 (if Touch-up treatment occurred)), and satisfaction with the treatment 4, 24 and 36 weeks after the treatment. The safety will be evaluated based on occurrence of adverse events, which will be collected throughout the investigation.

Conditions

Interventions

TypeNameDescription
DEVICEPrincess® VOLUME LidocainePrincess® VOLUME Lidocaine injections up to 10 ml given to the patients at baseline, and touch-up at week 2, if applicable

Timeline

Start date
2016-12-27
Primary completion
2017-07-18
Completion
2017-10-17
First posted
2017-02-13
Last updated
2025-06-04
Results posted
2025-06-04

Locations

3 sites across 1 country: Austria

Source: ClinicalTrials.gov record NCT03050710. Inclusion in this directory is not an endorsement.